New hepatitis B drug to be released from December

Published: 2012-10-19 06:57:00
Updated: 2012-10-19 06:57:00
Gilead Sciences’ Viread (tenofovir disoproxil fumarate) will be launched from December 1, according to Yuhan Corp., a local exclusive distributor.

Viread is indicated for the treatment of chronic hepatitis B in adults. The drug is administered as a once-daily tablet, and works by blocking HBV ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.